Aclaris Therapeutics Stock Predictions
Currently predicting for Tue, 30 May 2023Trading levels for ACRS
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 8.49 | 2.45 % | |
R2 | 8.42 | 1.51 % | ||
R1 | 8.37 | 0.92 % | ||
Current price: | 8.29 | |||
Support | S1 | 8.21 | -0.96 % | |
S2 | 8.16 | -1.55 % | ||
S3 | 8.08 | -2.49 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 8.95 | 7.96 % | |
R2 | 8.40 | 1.33 % | ||
R1 | 8.33 | 0.483 % | ||
Current price | 8.29 | |||
Support | S1 | 7.89 | -4.83% | |
S2 | 7.41 | -10.62% | ||
S3 | 7.07 | -14.72% |
ACRS Predictions History
2 years ago
j_ballough predicted that
ACRS
for 2021-04-06 is going
$21.73 (-25.02%)
2 years ago
pleek85.226346 predicted that
ACRS
for 2021-04-05 is going
2 years ago
jjsheets330 predicted that
ACRS
for 2021-03-23 is going
$28.00 (10.54%)
2 years ago
mobilebmwcoding.227006 predicted that
ACRS
for 2021-03-23 is going
3 years ago
Cory Hutting predicted that
ACRS
for 2019-11-11 is going
$1.95 (0.00%)
3 years ago
PumpTheseNumbers predicted that
ACRS
for 2019-11-04 is going
$1.90 (4.97%)
About Aclaris Therapeutics
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of... ACRS Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.